Safety and Efficacy of Sanaria's PfSPZ-CVac in Malian Adults

NCT02996695 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

62

Enrollment

NIH

Sponsor class

Conditions

Plasmodium Falciparum Infection

Interventions

DRUG: Artesunate
DRUG: Chloroquine
BIOLOGICAL: PfSPZ (NF54) Challenge
OTHER: Placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)